Myriad, AstraZeneca and MSD expand collaboration

5th April 2019 Uncategorised 0

The expansion will use BRACAnalysis CDx to identify germline BRCA mutations.

More: Myriad, AstraZeneca and MSD expand collaboration
Source: News